Humana (HUM) PT Raised to $330 at Argus

Argus raised its price target on Humana (NYSE: HUM) to $330.00 (from $270.00) while maintaining a Buy rating.

Analyst David Toung has a positive view on reports of an acquisition by Wal-Mart (NYSE: WMT). The analyst comments "We think such a merger would provide Humana with substantial benefits, as it could leverage the large customer base at Wal-Mart’s 5,300 U.S. retail locations to expand membership in its Medicare Advantage and other health plans. Humana could also use Wal-Mart stores to expand its network of care delivery clinics."

You May Also Be Interested In

• SpaceX's spectrum deal puts SIRI's satellite assets in focus
• Zeta Global Holdings Corp (ZETA) PT Raised to $38 at Truist Securities
• Amrize Ltd (AMRZ) PT Lowered to $40 at DA Davidson as FY26 Guidance 'at Risk'